Prescription Trends of Medications Used to Treat Sleep Disturbances in School-Aged Children: An Interrupted Time-Series Analysis in France, 2016-2023
Open Access
- 5 February 2025
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 280, 114502
Abstract
No abstract availableKeywords
Funding Information
- Fondation de France (APHP220322)
- Pfizer
- GlaxoSmithKline
- French National Research Agency (ANR-21-COVR-0010-01)
This publication has 52 references indexed in Scilit:
- European expert guidance on management of sleep onset insomnia and melatonin use in typically developing childrenEuropean Journal of Pediatrics, 2024
- Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 PandemicJAMA Network Open, 2024
- Early sleep duration trajectories and children’s cognitive development: a prospective cohort studyEuropean Journal of Pediatrics, 2023
- Trends in Acute Care Use for Mental Health Conditions Among Youth During the COVID-19 PandemicJAMA Psychiatry, 2023
- Changes in Depression and Anxiety Among Children and Adolescents From Before to During the COVID-19 PandemicJAMA Pediatrics, 2023
- Climbing Melatonin Use for Insomnia Raises Safety ConcernsJAMA, 2022
- Psychotropic Drug Use in Children and Adolescents Before and During the COVID-19 PandemicJAMA Pediatrics, 2022
- Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19JAMA Pediatrics, 2021
- Pediatric use of prescribed melatonin in Sweden 2006–2017: a register based studyEuropean Child & Adolescent Psychiatry, 2020
- Association Between Portable Screen-Based Media Device Access or Use and Sleep OutcomesJAMA Pediatrics, 2016